MAPT and Alzheimer disease: In parallel with these findings, we found phosphopeptides restricted to AD brains that correspond to the HLA class I histocompatibility antigen A alpha chain (MHC-I), Tau and TGF-beta signaling (e.g., E3 ubiquitin-protein ligase TRIM33).